New antifungal Drug's belly levels under microscope in ICU patients
NCT ID NCT07093203
First seen Apr 10, 2026 · Last updated May 21, 2026 · Updated 4 times
Summary
This study looks at how the antifungal drug rezafungin spreads into the abdominal cavity of critically ill patients with a serious fungal infection after abdominal surgery. Researchers will measure drug levels in the blood and in fluid from the abdomen to see if enough reaches the infection site. The goal is to understand dosing needs in this fragile group, not to test a cure. About 20 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICALLY ILL INTENSIVE CARE UNIT PATIENTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU de Nancy
RECRUITINGVandœuvre-lès-Nancy, Lorraine, 54500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.